Seroatlas · Human Serome Atlas

CDKN2D

Cyclin-dependent kinase 4 inhibitor D

Also known as: CDN2D_HUMAN, INK4D, p19

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P55273
Gene
CDKN2D
Ensembl
ENSG00000129355
Chromosome
19
Canonical length
166 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

The protein encoded by this gene is a member of the INK4 family of cyclin-dependent kinase inhibitors. This protein has been shown to form a stable complex with CDK4 or CDK6, and prevent the activation of the CDK kinases, thus function as a cell growth regulator that controls cell cycle G1 progression. The abundance of the transcript of this gene was found to oscillate in a cell-cycle dependent manner with the lowest expression at mid G1 and a maximal expression during S phase. The negative regulation of the cell cycle involved in this protein was shown to participate in repressing neuronal proliferation, as well as spermatogenesis. Two alternatively spliced variants of this gene, which encode an identical protein, have been reported. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

166 residues, UniProt reviewed canonical sequence.

>P55273|CDKN2D
     1  MLLEEVRAGD RLSGAAARGD VQEVRRLLHR ELVHPDALNR FGKTALQVMM FGSTAIALEL
    61  LKQGASPNVQ DTSGTSPVHD AARTGFLDTL KVLVEHGADV NVPDGTGALP IHLAVQEGHT
   121  AVVSFLAAES DLHRRDARGL TPLELALQRG AQDLVDILQG HMVAPL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CDKN2D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
268 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 268 nTPM
  • cerebral cortex: 128 nTPM
  • amygdala: 111 nTPM
  • basal ganglia: 92 nTPM
  • hippocampal formation: 90 nTPM
  • thymus: 73 nTPM

Single-cell type

  • megakaryocytes: 2,263 nCPM
  • platelets: 1,543 nCPM
  • neutrophils: 561 nCPM
  • neutrophil progenitors: 222 nCPM
  • late primary spermatocytes: 148 nCPM
  • pdcs: 140 nCPM

Immune cell

  • basophil: 144 nTPM
  • neutrophil: 141 nTPM
  • eosinophil: 80 nTPM
  • memory B-cell: 57 nTPM
  • plasmacytoid DC: 51 nTPM
  • naive B-cell: 50 nTPM

Brain region

  • cerebral cortex: 83 nTPM
  • basal ganglia: 67 nTPM
  • hippocampal formation: 62 nTPM
  • pons: 61 nTPM
  • amygdala: 60 nTPM
  • hypothalamus: 60 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.39
gnomAD pLI
0.49
gnomAD missense Z
1.13
DepMap mean gene effect
-0.06
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CDKN2D in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CDKN2D as an antibody target. Whether an autoantibody or antibody against CDKN2D could matter depends on whether native CDKN2D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CDKN2D is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CDKN2D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CDKN2D. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...